Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3 - Hallo friendsTHE LEK NEWS, In the article you read this time with the title Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article culture, Article economy, Article health, Article healthy tips, Article news, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3
link : Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3

Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3

SOF/VEL and Resistance-associated Substitutions in HCV GT3

Alimentary Pharmacology & Therapeutics, June 21, 2018
J. von Felden; J. Vermehren; P. Ingiliz; S. Mauss; T. Lutz; K. G. Simon; H. W. Busch; A. Baumgarten; K. Schewe; D. Hueppe; C. Boesecke; J. K. Rockstroh; M. Daeumer; N. Luebke; J. Timm; J. Schulze zur Wiesch; C. Sarrazin; S. Christensen

Does the presence of resistance-associated substitutions impact the efficacy of therapy with sofosbuvir/velpatasvir with or without ribavirin in patients with HCV genotype 3?
Medscape - Full Text

Abstract and Introduction
Abstract
Background Twelve weeks of the pangenotypic direct–acting antiviral (DAA) combination sofosbuvir/velpatasvir (SOF/VEL) was highly efficient in patients with hepatitis C virus (HCV) genotype 3 (GT3) infection in the ASTRAL–3 approval study. However, presence of resistance–associated substitutions (RASs) in the HCV nonstructural protein 5A (NS5A) was associated with lower treatment response.

Aim To assess the efficacy and safety of SOF/VEL ± ribavirin (RBV) and the impact of NS5A RASs and RBV use on treatment outcome in HCV GT3 infection in a real–world setting.

View Full Article...…..

Free registration may be required.

Thus Article Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3

That's an article Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3 This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3 with the link address https://theleknews.blogspot.com/2018/06/sofosbuvirvelpatasvir-and-resistance.html

Tweet

Subscribe to receive free email updates: